Graduate and Doctor in Pharmacy from the Complutense University, Madrid in 1997. She wrote her doctoral thesis in the "Alberto Sols" Biomedical Research Institute (CSIC).

She was Visiting Researcher in the Scripps Research Institute, La Jolla, California, where she commenced her education in the field of genomic techniques. This has led her to international recognition in the application of these techniques to the understanding of thyroid pathologies.

Since 2007 she has held a PhD contract at the Rare Diseases Network (CIBERER) of the Biomedical Research Institute, Madrid.

Her main line of research has centred on study of the action of thyroid hormones in the development and working of the brain and the pathologies resulting from their inappropriate action. She has made major contributions in this field, most especially the contribution of the hypothesis now accepted regarding the role of the receptor without a ligand in hypothyroidism, the proof at a genic level of the effect of thyroid hormone on the development of the foetal brain, and study of the effect on the brain of thyroid hormone analogues, all of which are highly relevant for understanding the pathology of the Allan-Herdon-Dudley syndrome.

Currently, as well as her research work, she is making a major effort in the identification of patients with this disease by preparing and publishing a clinical guide and offering genetic diagnosis, which had not previously been available in our country.

Scientific production

• Paper at international conferences: 1